Convatec Group PLC (LON:CTEC)
London · Delayed Price · Currency is GBP · Price in GBX 230.40
+0.60 (0.26%)
Dec 15, 2025, 4:29 PM BST
Convatec Group Market Cap
Convatec Group has a market cap or net worth of 4.48 billion as of December 15, 2025. Its market cap has decreased by -7.45% in one year.
Market Cap
4.48B
Enterprise Value
5.39B
Revenue
1.72B
Ranking
n/a
PE Ratio
29.75
Stock Price
230.40
Market Cap Chart
Since October 26, 2016, Convatec Group's market cap has increased from 4.39B to 4.48B, an increase of 2.11%. That is a compound annual growth rate of 0.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 4.48B | -1.01% |
| Dec 31, 2024 | 4.53B | -9.11% |
| Dec 29, 2023 | 4.98B | 4.77% |
| Dec 30, 2022 | 4.75B | 22.28% |
| Dec 31, 2021 | 3.89B | -2.42% |
| Dec 31, 2020 | 3.98B | 1.32% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 208.48B |
| GSK plc | 73.26B |
| Haleon | 31.93B |
| Smith & Nephew | 10.33B |
| Hikma Pharmaceuticals | 3.36B |
| HUTCHMED (China) | 1.75B |
| Genus | 1.67B |
| Oxford Nanopore Technologies | 1.21B |